Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Consolidated Net Profit

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹2,191 Cr₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr

What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?

The latest Consolidated Net Profit ratio of DIVIS LABORATORIES is ₹2,191 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹2,191 Cr
Mar2024₹1,600 Cr
Mar2023₹1,824 Cr
Mar2022₹2,960 Cr
Mar2021₹1,984 Cr

How is Consolidated Net Profit of DIVIS LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹2,191 Cr
36.94
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr -

Compare Consolidated Net Profit of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹162,472.7 Cr 5.3% -3.4% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics
MANKIND PHARMA ₹85,816.7 Cr 3% -3.9% -15.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

5.3%

-3.4%

3.4%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses